Search

Home > GRACEcast Lung Cancer Video > Should PD-L1 be Used as a Biomarker for Immunotherapy in Lung Cancer?
Podcast: GRACEcast Lung Cancer Video
Episode:

Should PD-L1 be Used as a Biomarker for Immunotherapy in Lung Cancer?
Category: Science & Medicine
Duration: 00:05:06
Publish Date: 2015-11-11 14:00:00
Description:

Dr. Eddie Garon, UCLA, reviews the controversial question of whether PD-L1 expression is a reliable enough biomarker to be used to select patients to receive or not receive immune checkpoint inhibitor therapy in lung cancer.
Total Play: 0